With a focus on effectively engaging genetic therapy patients, the 2nd Annual Gene Therapy Summit is a must attend conference for individuals and companies that are serious about building safer and more meaningful gene therapy programs. The summit will unite patient advocacy and engagement leaders from gene therapy and gene editing drug developers, patient groups and patients themselves to address the specific challenges of patient engagement in genetic therapy and will generate actionable insights through detailed case studies and open discussions.
As gene therapies proliferate and sector investment continues to grow rapidly, engaging with gene therapy patients effectively throughout development has become a priority and a necessity to enhance efficacy.
The conference features experts from companies and institutions including Spark Therapeutics, Ultragenyx, FDA, Global Genes, and CRISPR Therapeutics on key topics to ensure effective creation and implementation of patient-centric gene therapy programs.
To learn more, please visit: https://ibn.fm/Pklyu